Bortezomib-Induced Bronchiolitis Obliterans Organizing Pneumonia
Introduction. Bortezomib is a proteasome inhibitor indicated for the treatment of multiple myeloma patients. The most frequent side effects are gastrointestinal and neurological. Serious pulmonary complications have been described rarely. Observation. This case involves a 74-year-old man suffering f...
Saved in:
Main Authors: | E. Vandeix, F. Favard, N. Pichon, M. Delage-Corre, B. Melloni, M. Clavel |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Case Reports in Pulmonology |
Online Access: | http://dx.doi.org/10.1155/2012/430141 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rituximab-Induced Bronchiolitis Obliterans Organizing Pneumonia
by: Ahmet B. Ergin, et al.
Published: (2012-01-01) -
Polyarteritis Nodosa and Bronchiolitis Obliterans with Organizing Pneumonia, an Unusual Association
by: Kaberi Dasgupta, et al.
Published: (1997-01-01) -
The Burden of Cost in Bronchiolitis Obliterans Syndrome: Predictions for the Next Decade
by: Christopher A. Jones, et al.
Published: (2016-06-01) -
Association between Polyunsaturated Fatty Acid Profile and Bronchial Inflammation in Bronchiolitis Obliterans
by: Silvija P. Jerkic, et al.
Published: (2023-01-01) -
Effect of Maintenance Azithromycin on Established Bronchiolitis Obliterans Syndrome in Lung Transplant Patients
by: Nancy R Porhownik, et al.
Published: (2008-01-01)